Journals / Veterinary Sciences and Practices / 2017 / Cilt: 12 Sayı: 2

Effect of Ethyl Pyruvate on Carbon Tetrachloride (CCl4)-Induced Coagulation Disturbances in Rats

Sıçanlarda Karbon Tetraklorürün (CCl4) Neden Olduğu Koagülasyon Bozukluklarında Etil Pirüvatın Etkisi

Pages
137–142
Publication Date
2017-10-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This effect of ethyl pyruvate may be useful for preventing haemostatic disturbances associated with liver diseases

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The effect of ethyl pyruvate (EP) on carbon tetrachloride (CCl4)-induced haemostatic disturbances in rats was investigated in this study.
📊
Key Findings & Data:The control group was given intraperitoneally 1 ml of Ringer’s lactate solution at 0 h, 1,5 h and 6 hours.
💡
Conclusion & Impact:This effect of ethyl pyruvate may be useful for preventing haemostatic disturbances associated with liver diseases
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Etil pirüvat · Karbon tetraklorür · Pıhtılaşma bozuklukları

Abstract

The effect of ethyl pyruvate (EP) on carbon tetrachloride (CCl4)-induced haemostatic disturbances in rats was investigated in this study. Forty male Sprague-Dawley rats were divided into four equal groups. The control group was given intraperitoneally 1 ml of Ringer’s lactate solution at 0 h, 1,5 h and 6 hours. The CCl4 group was treated intraperitoneally with a single dose of 1.6 g/kg CCl4 followed by the administration of 1 ml Ringer’s lactate solution at at 1,5 and 6 hours. The ethyl pyruvate group was injected intraperitoneally with ethyl pyruvate at a dose of 40 mg/kg at 0, 1,5 and 6 hours. The ethyl pyruvate +CCl4 group were administered intraperitoneally with ethyl pyruvate at a dose of 40 mg/kg at 30 min before and at 1 and 6 h after a single dose of 1.6 g/kg CCl4 injection.Treatment of CCl4 prolonged prothrombin time (PT) and activated thromboplastin time (aPTT), decreased fibrinogen level and increased alanine aminotranspherase (ALT) activity. On the other hand, the administration of EP intraperitoneally at 30 minutes before, and at 1.5 and 6 h after CCl4 significantly (P<0.05) decreased PT, aPTT and ALT values and increased (P<0.05) fibrinogen level when compared with CCl4-treated only group. The results of our study suggest that ethyl pyruvate treatment plays a protective role on CCl4-induced coagulation disturbances in rats. This effect of ethyl pyruvate may be useful for preventing haemostatic disturbances associated with liver diseases

Özet

Çalışmada, sıçanlarda karbon tetraklorürün (CCl4) neden olduğu koagülasyon bozukluklarında etil pirüvatın (EP) etkisi araştırıldı. Kırk erkek Sprague Dawley ırkı sıçan dört eşit gruba ayrıldı. Kontrol grubuna 1 ml Ringer laktat solüsyonu 0., 1,5. ve 6. saatlerde periton içi verildi. Karbon tetraklorür grubuna 1.6 g/kg CCl4 periton içi yolla tek doz verilmesini takiben 1.5 ve 6 saat sonra 1 ml Ringer laktat uygulandı. Etil pirüvat grubuna 40 mg/kg dozda etil pirüvat 0, 1.5 ve 6. saatlerde periton içi enjekte edildi. Etil pirüvat+CCl4 grubuna ise tek doz 1.6 g/kg CCl4 uygulamasından 30 dak. önce ve 1 ve 6 saat sonra 40 mg/kg dozda etil pirüvat periton içi uygulandı. Karbon tetraklorür, protrombin zamanı (PTZ) ve aktive parsiyel tromboplastin zamanı (aPTT) değerlerinde uzama (P<0.05), fibrinojen düzeyinde azalma (P<0.05) ve alanin aminotransferaz (ALT) aktivitesinde artma (P<0.05) oluşturdu. Öte yandan, CCl4 grubuyla karşılaştırıldığında, CCl4 uygulamasından 30 dak. önce ve 1 ve 6 saat sonra 40 mg/kg dozda verilen etil pirüvat fibrinojen düzeyini artırırken (P<0.05) PTZ ve aPTT sürelerinde ve ALT aktivitesinde azalmaya (P<0.05) neden oldu. Sonuç olarak, etil pirüvatın sıçanlarda CCl4’ün neden olduğu pıhtılaşma bozuklukları üzerine koruyucu bir etki gösterebileceği tespit edildi. Etil pirüvatın bu etkisi, karaciğer hastalıklarıyla ilişkili pıhtılaşma bozukluklarının önlenmesinde yararlı olabilir.

🔖

Cite This Article

Çetin, E. (2017). Effect of Ethyl Pyruvate on Carbon Tetrachloride (CCl4)-Induced Coagulation Disturbances in Rats. Veterinary Sciences and Practices, Cilt: 12 Sayı: 2, 137–142. https://ajindex.com/articles/917649

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. O'Donnell-Tormey J., Nathan CF., Lanks K., DeBoer CJ., de la Harpe J., 1987. Secretion of pyruvate: an antioxidant defense of mammalian cells. J Exp Med, 165, 500–514
  2. Uchiyama T., Delude RL., Fink MP., 2003. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med, 29, 2050-2058
  3. Salahudeen AK., Clark EC., Nath KA., 1991. Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Investing, 88, 1886-1893
  4. Bunger R., Mallet RT., Hartman DA., 1989. Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart: near complete prevention of reperfusion contractile failure. Eur J Biochem, 180, 221-233
  5. Cicalese L., Lee K., Schraut W., Watkins S., Borle A., Stanko R., 1999. Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. The Am J Surg, 171, 97-100
  6. Sileri P., Schena S., Morini S., Rastellini C., Pham S., Benedetti E., Cicalese L., 2001. Pyruvate inhibits hepatic ischemi reperfusion injury in rats. Transplant, 72, 27-30
  7. Tawadrous ZS., Delude RL., Fink MP., 2002. Resuscitation from hemorrhagic shock with Ringer’s ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock, 17, 473-477
  8. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura CJ., Fink MP., Tracey KJ., 2002. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. PNAS, 99, 12351-12356
  9. Yang R., Uchiyama T., Alber SM., Han X., Watkins SK., Delude RL., Fink MP., 2004. Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med, 32, 1453-1459
  10. Epperly M., Jin S., Nie S., Cao S., Zhang X., Franicola D., Wang H., Fink MP., Greenberger JS., 2007. Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiation. Radiat Res, 168, 552-559
  11. Wang LV., Wang LK., Chen H., Fan C., Li X., He CM., Gong ZJ., 2012. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats, World J Gastroenterol, 18, 5709-5718
  12. Hatch GE., Santrock J., Slade R., Hayes JM., 1988. Detection of CCL4-induced oxidation of hepatic tissue in vivo by oxigen-18 tracing. Toxicol Appl Pharmacol, 93, 81-88
  13. Okazaki M., Zhang LS., Suzuki M., Sakamoto K., 1988. The measurement of platelet aggregation and ATP-release in